Telomere Length in White Blood Cell Dna and Lung Cancer: A Pooled Analysis of Three Prospective Cohorts
Wei Jie Seow,Richard Cawthon,Mark Purdue,Wei Hu,Yu-Tang Gao,Wen-Yi Huang,Stephanie J. Weinstein,Bu-Tian Ji,Jarmo Virtamo,Dean Hosgood,Bryan Bassig,Xiaoou Shu,Qiuyin Cai,Yongbin Xiang,Shen Min,Wong-Ho Chow,Sonja Berndt,Christopher Kim,Unhee Lim,Demetrius Albanes,Neil E. Caporaso,Stephen Chanock,Wei Zheng,Nathaniel Rothman,Qing Lan
DOI: https://doi.org/10.1158/0008-5472.can-14-0459
IF: 11.2
2014-01-01
Cancer Research
Abstract:We investigated the relationship between telomere length and lung cancer in a pooled analysis from three prospective cohort studies: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial, conducted among men and women in the United States, and previously published data from the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Trial conducted among male smokers in Finland, and the Shanghai Women's Health Study (SWHS), which is comprised primarily of never-smokers. The pooled population included 847 cases and 847 controls matched by study, age, and sex. Leukocyte telomere length was measured by a monochrome multiplex qPCR assay. We used conditional logistic regression models to calculate ORs and their 95% confidence intervals (CI) for the association between telomere length and lung cancer risk, adjusted for age and pack-years of smoking. Longer telomere length was associated with increased lung cancer risk in the pooled analysis [OR (95% CI) by quartile: 1.00; 1.24 (0.90-1.71); 1.27 (0.91-1.78); and 1.86 (1.33-2.62); P trend = 0.000022]. Findings were consistent across the three cohorts and strongest for subjects with very long telomere length, i.e., lung cancer risks for telomere length [OR (95% CI)] in the upper half of the fourth quartile were 2.41 (1.28-4.52), 2.16 (1.11-4.23), and 3.02(1.39-6.58) for the PLCO trial, the ATBC trial, and the SWHS, respectively. In addition, the association persisted among cases diagnosed more than 6 years after blood collection and was particularly evident for female adenocarcinoma cases. Telomere length in white blood cell DNA may be a biomarker of future increased risk of lung cancer in diverse populations.